1 – 10 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
(
- Contribution to journal › Article
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
(
- Contribution to journal › Article
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
2024) In Science (New York, N.Y.)(
- Contribution to journal › Article
- 2023
-
Mark
A proteomics dataset capturing myeloid cell responses upon cellular exposure to fungicides, adjuvants and fungicide formulations
(
- Contribution to journal › Article
-
Mark
Single-cell analysis of myeloid cells in HPV+ tonsillar cancer
(
- Contribution to journal › Article
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
(
- Contribution to journal › Article
-
Mark
Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article